The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
20 categories

Regional

Geography-specific practicalities, kept separate so that country-specific answers do not get generalised.

38 topics1,713 posts8 solved Moderators: KLindqvist, j.mwangi About this category

38 topics

TopicParticipantsRepliesViewsActivity
EMA product information as a primary source — does this still hold?
The question in the title: EMA product information as a primary source — does this still hold? I will give what I have already checked below so nobody repeats it. Something about EMA product information does…
CCSGRWIAII+127 150 41k 20mo
Revisiting: German, French and Dutch differences, compared
Posting this under the heading it deserves: Revisiting: German, French and Dutch differences, compared Everything below is what sits behind that. I have spent a fortnight trying to pin German down and I want…
ITKSTHEDS+90 99 32k 9mo
Private prescribing in the UK: what is actually involved
On the subject in the title: Private prescribing in the UK: what is actually involved Working notes rather than a conclusion. The question about private prescribing that I actually want answered is the second…
SGTKVBRJJP+66 76 46k 14h
MHRA statements, read directly
MHRA statements, read directly Writing it up because I had to work it out twice and would rather nobody else did. Asking about MHRA statements directly, because I have read four threads on it and each…
VMSOGHTVJ+93 101 2.2k 5mo
Pharmacy supply in the UK and the questions you will be asked
On the subject in the title: Pharmacy supply in the UK and the questions you will be asked Working notes rather than a conclusion. Asking about pharmacy supply on behalf of the question I keep seeing asked…
CMCBRMNSP+95 105 1.3k 4mo
Telehealth prescribing models in the US
Telehealth prescribing models in the US Writing it up because I had to work it out twice and would rather nobody else did. Trying to work out what would count as evidence on telehealth prescribing models,…
SKBDKRVBDM+95 102 6.1k 14mo
Follow-up: State-level differences that actually matter
State-level differences that actually matter — setting out what I have, and where I think it stops being reliable. A follow-up question about State-level differences that I did not know to ask the first time.…
YRNJMFRRO+90 96 4.1k 4mo
UK access routes, dated and sourced — a second dataset
Posting this under the heading it deserves: UK access routes, dated and sourced — a second dataset Everything below is what sits behind that. Regional question, dated January 2026, because everything in this…
EMGBSTYEM+76 82 25k 14mo
Canadian access and provincial variation
Posting this under the heading it deserves: Canadian access and provincial variation Everything below is what sits behind that. Trying to establish the boundary conditions on canadian access and provincial…
POCLNNTPFV+74 80 7.7k 18mo
EMA product information as a primary source
Posting this under the heading it deserves: EMA product information as a primary source Everything below is what sits behind that. Something about EMA product information does not reconcile and I would like a…
YISVCDAMB+70 74 7k 8mo
US compounding rules and how they changed
US compounding rules and how they changed — setting out what I have, and where I think it stops being reliable. Reporting a regional experience with the date and the jurisdiction attached, because an undated…
VNJVBCBSAE+62 68 1.4k 20mo
Irish differences from the UK position
Posting this under the heading it deserves: Irish differences from the UK position Everything below is what sits behind that. Trying to establish the boundary conditions on irish differences. The general…
KOLNVPNCH+62 66 993 21mo
EU-wide position versus national implementation — what changed since
EU-wide position versus national implementation — what changed since Writing it up because I had to work it out twice and would rather nobody else did. What changes if the standard account of eu-wide position…
NMATTPBI+22 26 58k 2mo
NHS criteria and how they are applied in practice
NHS criteria and how they are applied in practice — setting out what I have, and where I think it stops being reliable. I was wrong about NHS criteria in a thread last spring and I would like to correct it…
AEUCRVTPAV+37 42 31k 2d
Second pass at: Pharmacy supply in the UK and the questions you will be asked
Second pass at: Pharmacy supply in the UK and the questions you will be asked Writing it up because I had to work it out twice and would rather nobody else did. Asking about Pharmacy supply on behalf of the…
DBDATFHKD+46 53 14k 12mo
Second pass at: Reimbursement variation across member states
On the subject in the title: Second pass at: Reimbursement variation across member states Working notes rather than a conclusion. The question about Reimbursement variation across member states that I…
APCDACBRSB+23 28 45k 21mo
Coming back to: Private prescribing in the UK: what is actually involved
Private prescribing in the UK: what is actually involved Writing it up because I had to work it out twice and would rather nobody else did. I would like to know what people here actually do about Private…
FNFLAWCFKB+62 67 2.1k 6mo
Cross-border purchase rules within the EU
On the subject in the title: Cross-border purchase rules within the EU Working notes rather than a conclusion. The question about cross-border purchase rules within that I actually want answered is the second…
HMEFVKGZA+45 49 15k 8mo
State-level differences that actually matter
On the subject in the title: State-level differences that actually matter Working notes rather than a conclusion. The question about state-level differences that I actually want answered is the second one…
TPJVSRGVGE+6 10 56k 10mo
Coverage in the US: a map of the usual obstacles
Coverage in the US: a map of the usual obstacles — setting out what I have, and where I think it stops being reliable. Trying to establish the boundary conditions on coverage. The general claim is fine; I…
GPMYASKHFA+46 50 7.9k 5mo
Second pass at: Coverage in the US: a map of the usual obstacles
On the subject in the title: Second pass at: Coverage in the US: a map of the usual obstacles Working notes rather than a conclusion. Two things I would like separated before anyone answers on Coverage,…
SAEDERSGAK 4 62k 9mo
[2026 update] US compounding rules and how they changed
US compounding rules and how they changed Writing it up because I had to work it out twice and would rather nobody else did. Regional question, dated January 2026, because everything in this category expires.…
FWTTAHECKH+32 37 7.4k 10mo
[2026 update] EU-wide position versus national implementation
On the subject in the title: EU-wide position versus national implementation Working notes rather than a conclusion. A methods question rather than a substantive one, about eu-wide position versus national…
FIANDT 2 54k 19mo
Canadian access and provincial variation — one year on
Canadian access and provincial variation — one year on Writing it up because I had to work it out twice and would rather nobody else did. A follow-up question about Canadian access and provincial variation…
EOHFCRJSRM+43 47 964 12mo
Coming back to: Telehealth prescribing models in the US
Posting this under the heading it deserves: Telehealth prescribing models in the US Everything below is what sits behind that. Telehealth prescribing models — I have the observation and I do not trust my…
LCNBHFTIEM+26 30 17k 17h
Reimbursement variation across member states
Reimbursement variation across member states Writing it up because I had to work it out twice and would rather nobody else did. Asking about reimbursement variation across member states directly, because I…
SFJSREBS+7 11 39k 3mo
About the North America category
US and Canadian regulation, compounding, and coverage. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its author and a note. If the scope…
KTVEKCNB+3 7 43k 9mo
MHRA statements, read directly — the long version
On the subject in the title: MHRA statements, read directly — the long version Working notes rather than a conclusion. Asking about MHRA statements directly, because I have read four threads on it and each…
BRTDSL 2 44k 22mo
Follow-up: UK access routes, dated and sourced
On the subject in the title: UK access routes, dated and sourced Working notes rather than a conclusion. Regional question, dated March 2026, because everything in this category expires. The position differs…
APSRNVEOVF+10 14 27k 2d
EU-wide position versus national implementation
EU-wide position versus national implementation Writing it up because I had to work it out twice and would rather nobody else did. Eu-wide position versus national implementation: what I expected, what I…
BBCLSGLEVK+22 29 356 11mo